CoreAge Rx vs Care Bare Rx
Two GLP-1 desks, one scoreboard. We put CoreAge Rx and Care Bare Rx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 72 on our six-factor Brief Score — The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
That doesn't make Care Bare Rx a bad call — it's best for readers who want an oral tirzepatide route or a brand pathway and will complete an intake to learn the cost. Weigh the six factors below against your own priorities before you decide.
Why CoreAge Rx leads: it's our #1 on the board — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| CoreAge Rx | Care Bare Rx | |
|---|---|---|
| Brief Score | 94/100 (A) | 72/100 (C) |
| Semaglutide | $149/mo | From $199/mo (shared figure) · brand Ozempic from $705/mo |
| Tirzepatide | $349/mo | Not separately disclosed |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Stableprice stable |
CoreAge Rx: Flat rate held for a third straight cycle — no first-month teaser to reset.
Care Bare Rx: One "$199" covers all weight-loss treatments; per-dose rates stay behind the intake quiz.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.